Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

Journal of Clinical Investigation(2023)10.1172/jci165476Source: DataRank Database

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 55 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access55 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 9.40)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (29)

Aisha Hasan ORCID,Ekaterina Doubrovina ORCID,Parastoo B. Dahi ORCID,Irene Rodriguez-Sanchez ORCID,Michael Curry ORCID

Live enrichment

PubMed:36951958 PMC:PMC10178844 OpenAlex:https://openalex.org/W4360600759

National Cancer Institute

Grant: P01 CA023766

National Cancer Institute

Grant: R21 CA162002

The Aubrey Fund

Grant: NA

National Cancer Institute

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5R21CA162002-02

EBV Specific T-cells from 3rd party donors for treatment of EBV-associated malign

National Institutes of Health

Grant: 5P01CA023766-14

MARROW TRANSPLANTATION IN LEUKEMIA AND OTHER DISEASES

FWCI

9.40

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.jci.org/articles/view/165476/files/pdf

publisherhttp://www.jci.org/articles/view/165476/files/pdf

publisherhttps://www.jci.org/articles/view/165476/files/pdf

journalhttps://doi.org/10.1172/jci165476

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36951958

Fields of Study

Cytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsToxoplasma gondii Research Studies0303 health sciences03 medical and health sciencesHumansChildCytomegalovirusViremiaHematopoietic Stem Cell TransplantationCytomegalovirus InfectionsCD8-Positive T-Lymphocytes

MeSH Terms

ChildCytomegalovirus InfectionsCytomegalovirusHumansViremiaHematopoietic Stem Cell TransplantationCD8-Positive T-Lymphocytes

Keywords

ViremiaCytomegalovirusImmunologyHaematopoiesisVirologyCytomegalovirus infectionsRefractory (planetary science)Hematopoietic cellMedicineBiologyHuman cytomegalovirusHerpesviridaeVirusViral diseaseStem cellGeneticsTransplantationT cellsInfectious diseaseImmunotherapyStem cell transplantationRHematopoietic Stem Cell TransplantationCD8-Positive T-LymphocytesHumansClinical MedicineChild

Sustainable Development Goals

SDG 0: Good health and well-being